Skip to main content
. 2020 Jul 14;38(33):5139–5147. doi: 10.1016/j.vaccine.2020.06.036

Table 1.

Primary inputs harmonized across models.

Input Value Sources
Target population by country Approximately 90 million pregnant women globally, per year United Nations Population Database, 2017 and Lawn et al., 2016 [11], [12]
Vaccine schedule Single dose provided year-round as part of ANC services Preferred Product Characteristics [13]; expert opinion
Vaccination window 24–36 weeks of gestation Preferred Product Characteristics [13]; expert opinion
Vaccine coverage by country Average in year 2023, 69% (21%–96%) DHS and WHO [14], [15]
Vaccine introduction dates by country Phased, 2023 to 2035 Product development timeline [8]; prior vaccine introduction
Vaccine efficacy for infant protection Midpoint 60% Preferred Product Characteristics [13]; expert opinion
Duration of protection Midpoint 5 months, no waning before 5 months Preferred Product Characteristics [13]; expert opinion

Abbreviations: ANC, antenatal care; DHS, Demographic and Health Surveys; WHO, World Health Organization.